Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- NASDAQ Technical Picture - Hanging Man to End Bullish Week
May 19, 2008 01:56 AM
- MediciNova to Present At the Rodman and Renshaw 5th Annual Global Healthcare Conference and Iomai shares surge on premium buyout offer
May 14, 2008 08:59 AM
- Retail Sales, M&A, & Fedspeak
May 13, 2008 09:56 AM
- Iomai, Merck Plan Proof-Of-Principle Studies On Patch
Apr 03, 2008 07:13 AM
- Iomai, Merck Plan Proof-Of-Principle Studies On Patch
Apr 03, 2008 07:13 AM
- UPDATE: Government Awards Contracts For Bird-Flu Medicine
Jan 17, 2007 05:28 PM
- GlaxoSmithKline, Novartis, Iomai Get H5N1 Vaccine Pacts
Jan 17, 2007 12:09 PM
- IPO REPORT: Israeli Venture Capitalist Eyes Nasdaq Listing From China
Nov 01, 2006 02:19 PM
- Iomai Stockholders Approve Merger With Intercell Subsidiary
Aug 01, 2008 09:19 AM
- Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today
Jun 19, 2008 08:31 AM
- Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine
Jun 11, 2008 06:30 PM
- Market Pulse Breaking News Alert for Wednesday, May 14, 2008: BCFT - Bancroft Uranium Updates Progress With First Nations and Initiates Program to Increase Monmouth Uranium Project Claim Holdings!
May 14, 2008 08:30 AM
- BellwetherReport.com Analyst Report on IOMI, EMKR, GIGM and MEDX
May 13, 2008 02:39 PM
- New Analyst Reports for STAPLES INC, IOMAI CORPORATION, IAC INTERACTIVECORP, and CHINA SUNERGY COMPANY LTD
May 13, 2008 01:10 PM
- Iomai to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT
May 12, 2008 08:47 PM
- Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
May 12, 2008 08:19 PM
- Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
Apr 15, 2008 08:04 AM
- Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine
Apr 08, 2008 08:31 AM
- Form 4 INTERCELL USA, INC. For: Aug 05 Filed by: Wilson Russell P (10K)
Aug 07, 2008 06:19 PM
- Form 4 INTERCELL USA, INC. For: Aug 05 Filed by: Vernon Thomas Martin Jr (10K)
Aug 07, 2008 06:18 PM
- Form 4 INTERCELL USA, INC. For: Aug 05 Filed by: Meyer F Weller (10K)
Aug 07, 2008 06:17 PM
- Form 4 INTERCELL USA, INC. For: Aug 05 Filed by: Glenn Gregory M (10K)
Aug 07, 2008 06:16 PM
- Form 4 INTERCELL USA, INC. For: Aug 05 Filed by: Erck Stanley C (10K)
Aug 07, 2008 06:14 PM
- Form 4 INTERCELL USA, INC. For: Aug 05 Filed by: DOUGLAS RICHARD (10K)
Aug 07, 2008 06:12 PM
- Form 4 INTERCELL USA, INC. For: Aug 05 Filed by: DOUGLAS R GORDON (10K)
Aug 07, 2008 06:09 PM
- Form 4 INTERCELL USA, INC. For: Aug 04 Filed by: TRAINOR III EUGENE A (10K)
Aug 06, 2008 06:17 PM
- Form 4 INTERCELL USA, INC. For: Aug 04 Filed by: BARRETT M JAMES (10K)
Aug 06, 2008 06:15 PM
- Form 4 INTERCELL AG For: Aug 01 (10K)
Aug 01, 2008 04:12 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
IOMI
|
Compare to S&P
|
| YTD |
-0.01 %
|
645.74 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -4.17 %
|
|
EPS Growth in Last Year: 43.18 %
|
|
Sales Growth in Last Quarter: -44.24 %
|
|
Sales Growth in Last Quarter: 15.87 %
|
|
|
